These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25034527)

  • 1. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.
    Xu D; Wang X; Yan S; Yin Y; Hou J; Wang X; Sun B
    Tumour Biol; 2014 Oct; 35(10):10267-73. PubMed ID: 25034527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPRO exaggerates inflammation in ulcerative colitis through TLR4/NF-κB pathway.
    Zhao J; Yan S; Zhu X; Bai W; Li J; Liang C
    J Cell Biochem; 2020 Feb; 121(2):1061-1071. PubMed ID: 31452237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
    Wang L; Zhu R; Huang Z; Li H; Zhu H
    Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.
    Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B
    J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggravated Liver Injury but Attenuated Inflammation in PTPRO-Deficient Mice Following LPS/D-GaIN Induced Fulminant Hepatitis.
    Wang X; Yan S; Xu D; Li J; Xie Y; Hou J; Jiang R; Zhang C; Sun B
    Cell Physiol Biochem; 2015; 37(1):214-24. PubMed ID: 26303994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPRO activates TLR4/NF-κB signaling to intensify lipopolysaccharide-induced pneumonia cell injury.
    Chen Y; Sun B
    Allergol Immunopathol (Madr); 2022; 50(3):119-124. PubMed ID: 35527665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4.
    Wei X; Liu H; Li X; Liu X
    Ann Hepatol; 2019; 18(6):869-878. PubMed ID: 31477445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway.
    Dong YQ; Lu CW; Zhang L; Yang J; Hameed W; Chen W
    Mol Immunol; 2015 Dec; 68(2 Pt C):671-83. PubMed ID: 26589455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.
    Hou J; Xu J; Jiang R; Wang Y; Chen C; Deng L; Huang X; Wang X; Sun B
    Hepatology; 2013 Feb; 57(2):678-88. PubMed ID: 22821478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
    Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
    Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTPRO Promotes Oxidized Low-Density Lipoprotein Induced Oxidative Stress and Cell Apoptosis through Toll-Like Receptor 4/Nuclear Factor κB Pathway.
    Liang C; Wang X; Hu J; Lian X; Zhu T; Zhang H; Gu N; Li J
    Cell Physiol Biochem; 2017; 42(2):495-505. PubMed ID: 28578349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HULC promotes lung squamous cell carcinoma by regulating PTPRO via NF-κB.
    Xu Y; Li J; Wang P; Zhang Z; Wang X
    J Cell Biochem; 2019 Dec; 120(12):19415-19421. PubMed ID: 31448453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.
    Hsu SH; Motiwala T; Roy S; Claus R; Mustafa M; Plass C; Freitas MA; Ghoshal K; Jacob ST
    J Cell Biochem; 2013 Aug; 114(8):1810-8. PubMed ID: 23533167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
    Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
    Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA.
    Chen IT; Cheng AC; Liu YT; Yan C; Cheng YC; Chang CF; Tseng PH
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
    Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
    Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncARSR/PTEN/Akt/nuclear factor-kappa B feedback regulatory loop contributes to doxorubicin resistance in hepatocellular carcinoma.
    Li Y; Li J; Chen H; Wang J; Jiang L; Tan X
    J Biochem Mol Toxicol; 2022 Sep; 36(9):e23119. PubMed ID: 35678308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
    Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW
    Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.